Professor Alvaro Cruz from Brazil, member of the GINA board of directors and GINA dissemination and implementation committee with 30 years’ experience caring for patients with asthma, examines the assessment of asthma control and identification of patients at risk.
Recent Posts
- A Meta-Analysis Investigating the Efficacy and Safety of Allergen-Specific Immunotherapy in the Management of Respiratory Allergies
- A Quarter of Patients With Mild Asthma Don’t Receive Guideline-Directed Therapy
- Computer fraud
- Recommendations for asthma monitoring in children: A PeARL document endorsed by APAPARI, EAACI, INTERASMA, REG, and WAO
- Asthma – how new medicines and services are improving lives?